Literature DB >> 15822901

Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies.

Irina V Balyasnikova1, Zenda L Woodman, Ronald F Albrecht, Ramanathan Natesh, K Ravi Acharya, Edward D Sturrock, Sergei M Danilov.   

Abstract

ACE chimeric proteins and N domain monoclonal antibodies (mAbs) were used to determine the influence of the N domain, and particular regions thereof, on the rate of ACE ectodomain shedding. Somatic ACE (having both N and C domains) was shed at a rate of 20%/24 h. Deletion of the C domain of somatic ACE generated an N domain construct (ACEDeltaC) which demonstrated the lowest rate of shedding (12%). However, deletion of the N domain of somatic ACE (ACEDeltaN) dramatically increased shedding (212%). Testicular ACE (tACE) having 36 amino acid residues (heavily O-glycosylated) at the N-terminus of the C domain shows a 4-fold decrease in the rate of shedding (49%) compared to that of ACEDeltaN. When the N-terminal region of the C domain was replaced with the corresponding homologous 141 amino acids of the N domain (N-delACE) the rate of shedding of the ACEDeltaN was only slightly decreased (174%), but shedding was still 3.5-fold more efficient than wild-type testicular ACE. Monoclonal antibodies specific for distinct, but overlapping, N-domain epitopes altered the rate of ACE shedding. The mAb 3G8 decreased the rate of shedding by 30%, whereas mAbs 9B9 and 3A5 stimulated ACE shedding 2- to 4-fold. Epitope mapping of these mAbs in conjunction with a homology model of ACE N domain structure, localized a region in the N-domain that may play a role in determining the relatively low rate of shedding of somatic ACE from the cell surface.

Mesh:

Substances:

Year:  2005        PMID: 15822901     DOI: 10.1021/pr049859w

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.

Authors:  Zenda L Woodman; Sylva L U Schwager; Pierre Redelinghuys; Adriana K Carmona; Mario R W Ehlers; Edward D Sturrock
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

2.  COVID-19-A theory of autoimmunity to ACE-2.

Authors:  Philip McMillan; Bruce D Uhal
Journal:  MOJ Immunol       Date:  2020-05-27

3.  Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain.

Authors:  Sergei M Danilov; Sergey Kalinin; Zhenlong Chen; Elena I Vinokour; Andrew B Nesterovitch; David E Schwartz; Olivier Gribouval; Marie-Claire Gubler; Richard D Minshall
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

4.  A small region in the angiotensin-converting enzyme distal ectodomain is required for cleavage-secretion of the protein at the plasma membrane.

Authors:  Saurabh Chattopadhyay; Goutam Karan; Indira Sen; Ganes C Sen
Journal:  Biochemistry       Date:  2008-07-18       Impact factor: 3.162

5.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

6.  An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding.

Authors:  Sergei M Danilov; Kerry Gordon; Andrew B Nesterovitch; Heinrich Lünsdorf; Zhenlong Chen; Maricela Castellon; Isolda A Popova; Sergey Kalinin; Emma Mendonca; Pavel A Petukhov; David E Schwartz; Richard D Minshall; Edward D Sturrock
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

7.  Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding.

Authors:  Sergei M Danilov; Heinrich Lünsdorf; Henry T Akinbi; Andrew B Nesterovitch; Yuliya Epshtein; Eleftheria Letsiou; Olga V Kryukova; Tobias Piegeler; Elena Z Golukhova; David E Schwartz; Randal O Dull; Richard D Minshall; Olga A Kost; Joe G N Garcia
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

8.  Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE.

Authors:  Andrew B Nesterovitch; Kyle D Hogarth; Vyacheslav A Adarichev; Elena I Vinokour; David E Schwartz; Julian Solway; Sergei M Danilov
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.